ASCLS eNewsBytes

• Multiparametric MRI Shows Promise in Breast Cancer Subtyping July 21, 2026
  Multiparametric MRI could help distinguish between luminal and non-luminal invasive ductal carcinoma, the most common type of breast cancer, with high accuracy, according to a prospective study, offering clinicians a potential non-invasive adjunct to histopathology when planning personalised treatment.
• Managing Diabetes and HIV Together July 21, 2026
  Scientific advances have turned HIV from a fatal disease in the 1980s into a manageable chronic condition, allowing individuals to achieve near-normal life expectancies. However, as this population ages, they become more vulnerable to age-related issues, such as type 2 diabetes, which significantly affects long-term health outcomes in people with HIV.
• EPA Revises List of Disinfectants for Combating Bloodborne Pathogens July 21, 2026
  The U.S. Environmental Protection Agency has created a new list titled EPA-Registered Antimicrobial Products Effective Against Bloodborne Pathogens, consolidating and updating information from various disinfectant lists that target HIV, Hepatitis B and Hepatitis C.
• FDA Approves Orca—T, a Nex-Gen HSCT to Reduce GVHD July 21, 2026
  The FDA has approved Orca-T for matched-donor hematopoietic stem cell transplants, enhancing hematopoietic and immunologic reconstitution and improving chronic graft-versus-host disease-free survival in adults with hematologic malignancies.
• Genetic Testing May Benefit More Patients With Melanoma July 21, 2026
  Researchers identified that young melanoma patients or those with multiple melanomas are more likely to have a genetic mutation, indicating that these individuals could benefit from genetic testing to assess mutations and cancer risk.